跳至主要内容
临床试验/IRCT201604179014N96
IRCT201604179014N96已完成2 期

Effect of omega-3 versus placebo on the clinical and paraclinical situation in patients with refractory epilepsy: a triple blind randomized clinical trial

Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • (a) age of 18 to 55 years; (b) having refractory epilepsy.
  • Exclusion criteria: (a) pregnancy or breastfeeding; (b) having underling diseases such as lever disease, kidney disease, active infection, pulmonary disease, hypertension, dementia, and mental retardation; (c) catamenial epilepsy.

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences

相似试验